Hava Teke-Uskudar

Eskisehir, 26040, Turkey

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

Macrocytosis as an Early Pharmacodynamic Marker of Imatinib Efficacy in Chronic Myeloid Leukemia.

Macrocytosis as an Early Pharmacodynamic Marker of Imatinib Efficacy in Chronic Myeloid Leukemia.

Journal: Journal of clinical medicine
Published: November 20, 2025

Mutant p.Val114Ala Transthyretin-Related Cardiac Amyloidosis with Heart Failure and Right Bundle Branch Block.

Mutant p.Val114Ala Transthyretin-Related Cardiac Amyloidosis with Heart Failure and Right Bundle Branch Block.

Journal: Anatolian journal of cardiology
Published: May 20, 2025

Utility of Leukocyte Volume, Conductivity and Scatter Parameters in the Diagnosis and Follow-Up of Infections.

Utility of Leukocyte Volume, Conductivity and Scatter Parameters in the Diagnosis and Follow-Up of Infections.

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
Published: August 29, 2024

The Most Predictive Red Flags for Suspecting Cardiac Amyloidosis in Patients with Heart Failure with Preserved Ejection Fraction.

The Most Predictive Red Flags for Suspecting Cardiac Amyloidosis in Patients with Heart Failure with Preserved Ejection Fraction.

Journal: Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir
Published: June 03, 2024

Management of Relapsed Hodgkin Lymphoma During the Second Trimester of Pregnancy: Case Report.

Management of Relapsed Hodgkin Lymphoma During the Second Trimester of Pregnancy: Case Report.

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: February 28, 2023

The Impact of Cytogenetic Aberrations in the Clonal Evolution of Chronic Myeloid Leukemia: A Single-Center Experience Among 450 Turkish Patients (Cohort Study)

The Impact of Cytogenetic Aberrations in the Clonal Evolution of Chronic Myeloid Leukemia: A Single-Center Experience Among 450 Turkish Patients (Cohort Study)

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: October 06, 2022

An overlooked entity in rheumatology practice: passive transfer of anti-HBc after intravenous immunoglobulin infusion.

An overlooked entity in rheumatology practice: passive transfer of anti-HBc after intravenous immunoglobulin infusion.

Journal: Clinical and experimental rheumatology
Published: April 15, 2022

Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies

Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: September 15, 2021

Evaluation and Differential Diagnosis of Hypereosinophilia in Rheumatology Practice.

Evaluation and Differential Diagnosis of Hypereosinophilia in Rheumatology Practice.

Journal: International archives of allergy and immunology
Published: June 06, 2021

Evaluation of hyperferritinemia causes in rheumatology practice: a retrospective, single-center experience.

Evaluation of hyperferritinemia causes in rheumatology practice: a retrospective, single-center experience.

Journal: Rheumatology international
Published: May 20, 2021

Weekly low-dose recombinant factor VIIa prophylaxis in Glanzmann thrombasthenia.

Weekly low-dose recombinant factor VIIa prophylaxis in Glanzmann thrombasthenia.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Published: April 20, 2021

Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?

Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?

Journal: Molecular cytogenetics
Published: October 08, 2020
Showing 1-12 of 36

Last Updated: 09/26/2026